Treatment of @entity3444 With Percutaneous XXXX .

@entity1 @entity3444 @entity9156 @entity1503 @entity158 @entity1411
UNASSIGNED: Plantar @entity9156 , the most common cause of @entity158 in the inferior heel, accounts for 11% to 15% of all foot symptoms requiring professional care among adults. The present study reports the results of a minimally invasive surgical treatment of @entity3444 . All @entity1 with @entity3444 who had undergone percutaneous @entity1411 at 3 clinical sites from March 2008 to March 2009 were included in the present study. The follow-up evaluations for this treatment were conducted using the Mayo clinical scoring system. We investigated 17 @entity1 with recalcitrant @entity3444 who had undergone this treatment within a follow-up period of >= 13 months. All procedures were performed in the clinic with the @entity1 under local anesthesia. No wound @entity1503 occurred. At a mean follow-up period of 16.0      2.29 (range 13 to 21) months, significant improvement was seen in the preoperative mean Mayo score (from 12.06      2.54 to 89.76      4.28, p  <  .001) and no @entity1 had developed symptom recurrence. Also, none of the @entity1 had developed @entity158 . All @entity1 were able to return to regular shoe wear by 3  weeks postoperatively. The technique of @entity3444 with percutaneous @entity1411 could be a promising treatment option for @entity1 with recalcitrant @entity3444 .
